Home / News / Global Pharmaceutical Rapid Microbiology Testing Market to Reach Worth USD 6.2 Bn by 2022 – Credence Research

Global Pharmaceutical Rapid Microbiology Testing Market to Reach Worth USD 6.2 Bn by 2022 – Credence Research

According to the latest report published by Credence Research, Inc. “Pharmaceutical Rapid Microbiology Testing Market – (Technology Type – Immunology based Methods, Nucleic acid based amplification tests, Mass Spectrometry based Methods, Flow Cytometry based Methods, Growth-based detection technologies, and Biochemical Tests; Application – Raw Material testing, In-Process testing, Microbial limit testing, Bioburden assessment, Process water testing, environment monitoring and sterility testing): Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the market was valued at USD 3.4 Bn in 2015, and is expected to reach USD 6.2 Bn by 2022, expanding at a CAGR of 7.3% from 2016 to 2022.

Browse the full report Pharmaceutical Rapid Microbiology Testing Market: Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/pharmaceutical-rapid-microbiology-testing-market

Market Insights

Rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in pharmaceutical application as well as in other industrial settings. In addition, rapid microbiology tests offer faster and more accurate methods to assist in the rapid detection of microbes and early diagnosis, thus saving cost and inventory.

North America held the largest regional market, accounting for the market share of over 36% in 2015, and is anticipated to dominate the global rapid microbiology tests market during the forecast period 2016 to 2022. Large numbers of market-focused players providing wider range of product portfolio are the key to growth of the North America region.

Asia Pacific is expected to grow at a highest growth rate during the focus period, due to increase in the number of laboratories in these regions and up gradation of existing ones for automation of various instrumentation systems. Moreover, the market is wide open for advancing rapid diagnostic technologies to improve the turnaround time of the tests as compared to the conventional microbiology testing methods.

Among the technology types, nucleic acid amplification technique held the largest share in the rapid microbiology tests in the pharmaceutical industry market due to its low cost and high efficacy. Moreover, the wide applications of nucleic acid amplification testing would further fuel the market growth in the coming years. Growth based detection technologies are anticipated to grow at a highest growth rate during the forecast period due to its faster turnaround time and accuracy in the detection of the microbes.

Browse the full report at http://www.credenceresearch.com/report/pharmaceutical-rapid-microbiology-testing-market

The sterility testing application held the largest share in the global rapid microbiology tests in pharmaceutical market due its wide application in the final drug product and other applications. Process water testing is anticipated to witness the highest growth in the global rapid microbiology tests in the pharmaceutical industry market during the forecast period of 2016 to 2022.

Latest Reports:

Lateral Epicondylitis (Tennis Elbow) Market By Treatment Type (Painkillers And Nsaids, Corticosteroid Injections , Shock Wave Therapy, Surgery, Equipment And Other Products) – Growth, Share, Opportunities & Competitive Analysis, 2016 -2022

In Vitro Colorectal Cancer Screening Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2020

Hybrid Operating Room Market By Applications (Diagnostic Imaging), By Device (Operating Tables, Operating Room Lights, Surgical Booms Surgical Imaging Displays, Intraoperative Diagnostic Devices, Operating Room Communication), By End User (Hospitals, Clinics, Medical Research Institutes) – Growth, Share, Opportunities & Competitive Analysis, 2016 -2022

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

Contact:

Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research

 

Release ID: 5317

About Chris Smith

Check Also

400-400

Global Cholesterol Testing Market Size, Share, Growth, Outlook, strategies and Forecast to 2016: Acute Market Reports

Notes: Production, means the output of Cholesterol Testing Revenue, means the sales value of Cholesterol ...